Diagnostic Collaboration and Option Agreement Sample Contracts

DIAGNOSTIC COLLABORATION AND OPTION AGREEMENT

Diagnostic Collaboration and Option Agreement • May 15th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Delaware

• Contract Type
  Diagnostic Collaboration and Option Agreement
• Filed
  May 15th, 2009
• Company
  ARCA Biopharma, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Delaware

THIS DIAGNOSTIC COLLABORATION AND OPTION AGREEMENT (“Agreement”) is entered as of June 23, 2006 (the “Effective Date”), by and between CardioDx, INC., a Delaware corporation having a place of business located at 3183 Porter Drive, Palo Alto, CA 94304 (“CardioDx”) and ARCA DISCOVERY, INC., a Delaware corporation having a place of business at 1200 Seventeenth Street, Suite 620, Denver, Colorado 80202 (“ARCA”). CardioDx and ARCA may be referred to individually herein as a “Party” or collectively as the “Parties.”

FIRST AMENDMENT TO DIAGNOSTIC COLLABORATION AND OPTION AGREEMENT

Diagnostic Collaboration and Option Agreement • May 15th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Diagnostic Collaboration and Option Agreement
• Filed
  May 15th, 2009
• Company
  ARCA Biopharma, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This First Amendment to the Diagnostic Collaboration and Option Agreement (this “Amendment”) is made as of October 1, 2007, (the “Amendment Date”) by and between CardioDX, Inc., a Delaware corporation with its principal place of business at 3183 Porter Drive, Palo Alto, California 94304 (“CardioDX”) and ARCA Discovery, Inc., a Delaware corporation having a place of business at 1200 Seventeenth Street, Suite 620, Denver, Colorado 80202 (“ARCA”).